New Delhi, April 6 (PTI): Software services firm HCL Technologies has acquired C3i Solutions for $60 million, a move aimed at accelerating the Indian IT firm’s growth in life sciences and consumer services.
C3i Solutions is a wholly owned, independently operated subsidiary of Merck & Co, (known as MSD outside the US and Canada).
It provides multi-channel customer engagement services for life sciences and consumer packaged goods (CPG) industries.
“With this acquisition, HCL will complement its broad-based IT and business services capability with the additional depth that C3i has in the life sciences and CPG verticals,” the country’s fourth largest software firm HCL Technologies said in a statement.
C3i’s expertise in the clinical, pharmacovigilance, and pharma sales support domains and the strong partnership will enable HCL’s life sciences customers to become more patient-centric and offer services to IT and business stakeholders, it added.
“C3i’s capabilities provide HCL with an innovative and complementary services portfolio and a vast customer base to further strengthen HCL’s position as a leading technology solutions provider to the life sciences and consumer industries,” HCL Technologies president and CEO C. Vijayakumar said.
According to a regulatory filing, HCL Technologies, through its step down subsidiary — HCL America Inc — will acquire 100 per cent stock of Telerx Marketing that operates as C3i Solutions.
C3i’s revenue for the financial year ended December 31, 2017 stood at $199 million. It has over 3,700 people located in the U.S., India, Bulgaria, China, UK, and Japan.
